Skip to content
healthcare.dev

IRBESARTAN

NDC 62135-977, IRBESARTAN, tablet, from Chartwell RX, LLC.

Product NDC
62135-977
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077205
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-977 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRBESARTAN150 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]

Package NDCNDC-11Package
62135-977-306213509773030 TABLET in 1 BOTTLE (62135-977-30)
62135-977-906213509779090 TABLET in 1 BOTTLE (62135-977-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6eb0cb56-2e51-45ef-9fd5-5646cf9f78a3

Use it

Look up 62135-977 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-977 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-977. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.